News und Analysen
A Record Number of Americans Have Tried Marijuana, New Survey Shows
Marijuana: it was once a taboo topic, but is no longer.According to a newly released study from national pollster Gallup, more Americans than ever have tried marijuana.Gallup has been sporadically....
Up in Smoke: This Marijuana Stock Lost More Than Half Its Value Last Week
As a whole, marijuana stocks are on fire. Through about mid-July, the average marijuana stock was up over 300% on a trailing-12-month basis, albeit one stock with a 2,363% gain at the time had skewed
Ionis Pharmaceuticals Inc: Growing Royalties, an Advancing Pipeline, and Getting Back Rights to Some Drugs
Ionis Pharmaceuticals (NASDAQ: IONS) reported second-quarter earnings earlier this week and then followed up on Friday with a disclosure that it's getting full rights back to two of its drugs
2 Marijuana Stocks That Turned $10,000 Into $125,000 and $300,000, Respectively
When it comes to top-performing industries, you'd have a tough time surpassing the returns of marijuana stocks. Of the 13 marijuana stocks with a market cap in excess of $200 million, over half have
Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today
Despite upbeat recent developments, shares of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) fell 15.3% during Wednesday's session. The biotech reported solid progress with clinical-stage candidates
The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors
When GW Pharmaceuticals (NASDAQ: GWPH) announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. There were at least
Dividendeneinnahmen im Juli 2017
Nachfolgend veröffentliche ich die Liste meiner Dividendeneinnahmen nach Steuerabzug im Juli 2017:Wertpapiername Dividende ALTRIA GRP INC. 39,52 € BK NOVA SCOTIA 30,47 € COCA-COLA CO. ....
Why GW Pharmaceuticals Could Be a Gold Mine for Growth Investors
You've probably heard of the great California gold rush of the mid-19th century. Today, many are flocking to what has been called the "green rush" -- a major wave of money flowing into the marijuana
Why AstraZeneca plc Stock Broke Down in July
Big Pharma stocks don't usually drop by double-digits over the course of a month, but that's exactly what happened to British pharma giant AstraZeneca plc (NYSE: AZN) in July. Due to the late-stage
Here's Why Amarin Corporation plc Is on the Rise Today
Shares of Amarin Corporation plc (NASDAQ: AMRN), a cardiovascular health-focused biotech, popped 12.9% higher this morning after reporting second-quarter earnings. Investors cheered the
5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You
The numbers didn't lie: Gilead Sciences (NASDAQ: GILD) posted pretty good second-quarter results. While revenue and earnings fell compared to the prior-year period, the big biotech still managed to
Better Buy: Cara Therapeutics Inc. vs. GW Pharmaceuticals plc
Cara Therapeutics Inc. (NASDAQ: CARA), and GW Pharmaceuticals plc (NASDAQ: GWPH) often get lumped in with a stack of risky marijuana stocks, because both are developing drugs derived from the
Why AstraZeneca Stock Is Crashing Today
British pharma giant AstraZeneca's (NYSE: AZN) comeback story took a major blow this morning after the company reported that the all-important Mystic trial assessing Imfinzi (durvalumab) in
The 3 Hottest Marijuana Stocks Right Now
Though it probably goes without saying, it should be noted that marijuana stocks have been on fire over the trailing year. All but one of the 13 marijuana stocks with market caps above $200 million
It Took Just 10 Days for Nevada's Recreational Marijuana Industry to Fall Into a State of Emergency
When discussing the fastest-growing industries on the planet, few, or none, may top the legal marijuana industry. According to cannabis research group ArcView, North American legal pot sales are
No Surprise! Amicus Therapeutics Hits Up Investors for More Cash
Amicus Therapeutics (NASDAQ: FOLD) will be able to submit its Fabry disease drug Galafold to the FDA for consideration, a reversal of fortune that sent shares skyrocketing earlier this week. While
Saschas Börsentag, Video-Börsen-Blog vom 1. März 2017
Heute bespreche ich neben meinem Musterdepot u.a. die Aktien von Volkswagen (VW), Commerzbank, Deutsche Bank, Talanx, Steinhoff International, Covestro, Hugo Boss, Rheinmetall, Aareal Bank, WCM
Atossa Genetics: Ein rätselhafter Kurssprung!
Liebe Leser,
bei Atossa Genetics aus Seattle, Washington stehen die Zeichen derzeit auf Hoffnung. Das Papier legte Mitte letzter Woche einen Zwischenspurt ein und gewann zeitweise rund 35....
AstraZeneca: Wettbewerb durch Generika!
Liebe Leser,
letzte Woche überschlugen sich die Nachrichten bei AstraZeneca (AZ), denn ganz ähnlich wie überall im Pharmabereich leidet der Konzern unter dem Verlust von Patenten, die für....
Mylan NV kann sich über deutliche Umsatzsteigerung freuen!
Liebe Leser,
Mylan hat in den ersten 9 Monaten den Umsatz um 12,5% gesteigert. Beide Sparten wuchsen ebenfalls um 12,5%: die Generika auf 6,7 Mrd $ und die Spezialitäten auf 1,07 Mrd $. Auch in....
AstraZeneca: Wettbewerb mit preisgünstigeren Generika drückt auf die Ergebnisse!
Liebe Leser,
frühere Kassenschlager wie Nexium, Crestor und Seroquel haben ihren Patentschutz verloren und stehen im Wettbewerb mit preisgünstigeren Generika. Das drückt auf die Ergebnisse. In....
GlaxoSmithKline und Alphabet-Tochter gründen Gemeinschaftsfirma
Liebe Leser,
das britische Pharmaunternehmen GlaxoSmithKline (GKS) macht gemeinsame Sache mit einem Tochterunternehmen der Google-Mutter Alphabet. Wie der Gesundheitskonzern erklärte, werde man gemeinsam
Shire und Baxalta: Der große Tag rückt näher
Lieber Leser,
Baxalta hat jüngst Datum für eine außerordentliche Aktionärsversammlung bekannt gegeben. Am 27. Mai sollen die Baxalta-Anleger darüber entscheiden, ob sie das Übernahmeangebot von Shire akzeptieren.
Form 8.3 - The Vanguard Group, Inc.: Horizon Discovery Group plc : AMENDMENT
Form 8.3 - The Vanguard Group, Inc.: Horizon Discovery Group plc : AMENDMENT
Form 8.3 - The Vanguard Group, Inc.: Horizon Discovery Group plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Discovery Group plc